EP Patent

EP1893559A2 — Process for preparation of sertraline hydrochloride form i

Assigned to Teva Pharmaceutical Industries Ltd · Expires 2008-03-05 · 18y expired

What this patent protects

Provided is a process for preparation of sertraline HCl Form I on an industrial scale comprising steps of : a) heating sertraline HCI in n-butanol to a temperature of about 400 C to about reflux temperature, and b) crystallizing sertraline HCI

USPTO Abstract

Provided is a process for preparation of sertraline HCl Form I on an industrial scale comprising steps of : a) heating sertraline HCI in n-butanol to a temperature of about 400 C to about reflux temperature, and b) crystallizing sertraline HCI

Drugs covered by this patent

Patent Metadata

Patent number
EP1893559A2
Jurisdiction
EP
Classification
—
Expires
2008-03-05
Drug substance claim
No
Drug product claim
No
Assignee
Teva Pharmaceutical Industries Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.